Tg Therapeutics (TGTX) Current Leases (2019 - 2026)

Tg Therapeutics' Current Leases history runs 8 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• In Q1 2026, Current Leases rose 63.26% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (up 63.26% YoY), while the FY2025 annual figure was $1.0 million, down 9.77% from the prior year.
• Current Leases was $1.8 million for Q1 2026 at Tg Therapeutics, up from $1.0 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.8 million in Q1 2026 to a low of $1.0 million in Q4 2025.
• Historically, Current Leases has averaged $1.4 million across 5 years, with a median of $1.4 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Current Leases fell 19.99% in 2024, then surged 63.26% in 2026.
• A 5-year view of Current Leases shows it stood at $1.6 million in 2022, then declined by 8.54% to $1.4 million in 2023, then retreated by 19.99% to $1.2 million in 2024, then dropped by 9.77% to $1.0 million in 2025, then soared by 74.52% to $1.8 million in 2026.
• The last three Current Leases figures came in at $1.8 million (Q1 2026), $1.0 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.